India's Sai Life at record high on results rally, Jefferies upgrade

Sai Life Sciences

11/08/2025 11:06

** Sai Life Sciences SAIE.NS shares rise as much as nearly 8.5% to peak at 897.7 rupees; closes the session 6.8% higher at 884, a record closing high

** Pharma contract research firm swings to Q1 profit of 604.55 mln rupees from 134.98 mln rupees loss YoY

** Stock up about 12% in two sessions post-earnings

** Jefferies upgrades SAIE to "buy" from "hold", hikes price target to street-high 1,000 rupees from 800 rupees, implying a potential upside of 26%

** Jefferies cites strong contract research and manufacturing performance, plans to double capacity within 18 months, and robust order visibility as key positives

** Average rating from three analysts is "buy", median PT is 964 rupees - data compiled by LSEG

** YTD, SAIE up 19%

 (Reporting by Bharath Rajeswaran in Bengaluru)

 ((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))